References
- KantorEDRehmCDHaasJSChanATGiovannucciELTrends in prescription drug use among adults in the United States from 1999–2012JAMA2015314171818183126529160
- PrattLABrodyDJGuQAntidepressant use in persons aged 12 and over: United States, 2005–2008NCHS Data Brief20117618
- CouplandCDhimanPMorrissRArthurABartonGHippisley-CoxJAntidepressant use and risk of adverse outcomes in older people: population based cohort studyBMJ2011343d455121810886
- KarkareSUBhattacharjeeSKamblePAparasuRPrevalence and predictors of antidepressant prescribing in nursing home residents in the United StatesAm J Geriatr Pharmacother20119210911921565710
- CarsonHJZweigartMLueckNEDeath from asthma associated with sertraline overdoseAm J Forensic Med Pathol200021327327510990292
- TurnerRCNelsonJERobertsBTGillamDMVenlafaxine-associated interstitial pneumonitisPharmacotherapy200525462662915977923
- BarnésMTBascuñanaJGarcíaBAlvarez-SalaJLAcute eosinophilic pneumonia associated with antidepressant agentsPharm World Sci199921524124210550851
- EspeletaVJMooreWHKanePBBaramDEosinophilic pneumonia due to duloxetineChest2007131390190317356112
- FleischMCBlauerFGublerJGKuhnMSchererTAEosinophilic pneumonia and respiratory failure associated with venlafaxine treatmentEur Respir J200015120520810678647
- ThorntonCMaherTMHansellDNicholsonAGWellsAUPulmonary fibrosis associated with psychotropic drug therapy: a case reportJ Med Case Rep2009312620062766
- TsigkaropoulouEHatziliaDRizosEVenlafaxine-induced acute eosinophilic pneumoniaGen Hosp Psychiatry2011334411.e7e9
- VázquezMJCarretero QuevedoBPneumonitis related to venlafaxinePsychosomatics2008491848518212183
- DrentMSinghSGorgelsAPDrug-induced pneumonitis and heart failure simultaneously associated with venlafaxineAm J Respir Crit Care Med2003167795896112663337
- de KervilerETrédanielJRevlonGFluoxetine-induced pulmonary granulomatosisEur Respir J1996936156178730028
- TorokNIDonaldsonBLTajiJAbugiazyaAAssalyRDiffuse alveolar damage and recurrent respiratory failure secondary to sertralineAm J Ther2012194e132e13520838205
- OhSChaSIKimHA case of venlafaxine-induced interstitial lung diseaseTuberc Respir Dis (Seoul)2014772818425237379
- FerreiraPGCostaSDiasNFerreiraAJFrancoFSimultaneous interstitial pneumonitis and cardiomyopathy induced by venlafaxineJ Bras Pneumol201440331331825029655
- CoultasDBZumwaltREBlackWCSobonyaREThe epidemiology of interstitial lung diseasesAm J Respir Crit Care Med199415049679727921471
- RaghuGWeyckerDEdelsbergJBradfordWZOsterGIncidence and prevalence of idiopathic pulmonary fibrosisAm J Respir Crit Care Med2006174781081616809633
- OlsonALSwigrisJJLezotteDCNorrisJMWilsonCGBrownKKMortality from pulmonary fibrosis increased in the United States from 1992 to 2003Am J Respir Crit Care Med2007176327728417478620
- GribbinJHubbardRBLe JeuneISmithCJWestJTataLJIncidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UKThorax2006611198098516844727
- KornumJBChristensenSGrijotaMThe incidence of interstitial lung disease 1995–2005: a Danish nationwide population-based studyBMC Pulm Med200882418983653
- ArakiTPutmanRKHatabuHDevelopment and progression of interstitial lung abnormalities in the Framingham Heart StudyAm J Respir Crit Care Med2016194121514152227314401
- RosenbergTAcute hospital use, nursing home placement, and mortality in a frail community-dwelling cohort managed with Primary Integrated Interdisciplinary Elder Care at HomeJ Am Geriatr Soc20126071340134622694020
- RockwoodKSongXMacKnightCA global clinical measure of fitness and frailty in elderly peopleCMAJ2005173548949516129869
- AllenJNDrug-induced eosinophilic lung diseaseClin Chest Med2004251778815062599
- MatsunoODrug-induced interstitial lung disease: mechanisms and best diagnostic approachesRespir Res2012133922651223
- CapelozziMALeick-MaldonadoEAParraERMartinsMATibérioIFCapelozziVLMorphological and functional determinants of fluoxetine (Prozac)-induced pulmonary disease in an experimental modelRespir Physiol Neurobiol2007156217117817056303
- ChangMTybringGDahlMLLindhJDImpact of cytochrome P450 2C19 polymorphisms on citalopram/escitalopram exposure: a systematic review and meta-analysisClin Pharmacokinet201453980181125154506
- NaranjoCABustoUSellersEMA method for estimating the probability of adverse drug reactionsClin Pharmacol Ther19813022392457249508